Dr. Stredrick joined the ODP in September 2010. She conducts a wide range of analysis and evaluation, fulfilling responsibilities with which the office is charged. She serves as the ODP representative on several NIH-wide and Federal Government agency-wide committees and assists in program planning and analysis for the HHS initiative, Healthy People. Healthy People is a set of health objectives for the Nation established every ten years. Dr. Stredrick is the executive secretary for the Prevention Research Coordinating Committee and the Prevention Research Subcommittee for Prevention Science, trans-NIH committees that foster state-of-the science prevention research across the NIH and that disseminate information about prevention-related activities sponsored by Federal and non-Federal organizations.
Prior to her position at ODP, Dr. Stredrick was a Health Science Analyst at the National Cancer Institute (NCI) Office of Science Planning and Assessment. Dr. Stredrick earned her Ph.D. in pharmacology from Wake Forest University, where her dissertation research focused on the molecular neurotoxicity of manganese. She was a Cancer Research Training Award postdoctoral fellow in the Laboratory of Population Genetics at NCI, where she studied the genetics of breast cancer. She received her Bachelor of Arts in biology from the University of North Carolina at Asheville.